Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers

Medical Science Monitor

Volumn 11, Issue 3, 2005, Pages

  Bobrzyński, Andrzej ^a   Konturek, Peter C ^b   Konturek, Stanisław J ^c,d   Płonka, Małgorzata ^c   Bielański, Władyslaw ^c   Karcz, Danuta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c University Medical College   (Poland)

^d University Med Collage   (Poland)

Author keywords

Aspirin; Bleeding; H. pylori; NSAID; Perforation

Indexed keywords

ACETYLSALICYLIC ACID; CAGA PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; VACUOLATING TOXIN;

ADULT; AGE; AGED; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; INFECTION RATE; MAJOR CLINICAL STUDY; PEPTIC ULCER; PEPTIC ULCER BLEEDING; ULCER PERFORATION;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREATH TESTS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; POLAND; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 15944388596     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bobrzynski A, Beben P, Budzynski A et al: Incidence of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication. Med Sci Monit, 2002; 8(8): 554-557
2. Aalykke C, Lauritsen JM, Hallas J et al: Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: case-control study. Gastroenterology, 1999; 116: 1305-9
3. Wu CY, Poon SK, Chen GH et al: Interaction between Helicobacter pylori and non-steroidal anti-inflammatury drugs in peptic ulcer bleeding. Scand J Gastroenterol, 1999; 34: 234-37
4. Gisbert JP, Gonzales L, de Pedro A et al: Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role on non-steroidal anti-inflammatory drugs. Scand J Gastroenterol, 2001; 36: 717-24
5. Vaira D, Menegatti M, Miglioli M: What is the role of Helicobacter pylori in complicated ulcer disease? Gastroenterology, 1997; 113: S78-84
6. Hawkey CJ, Tulassay Z, Szczepanski L: Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP, NSAIDs Study. Lancet, 1998; 352: 1016-21
7. Konturek SJ, Bielanski W, Plonka M et al: Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcer. Scand J Gastroenterol, 2003; 38: 923-30
8. Gisbert JP, Pajares JM: Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment. Helicobacter, 2003; 8: 159-67
9. Gisbert JP, Legido J, Garcia-Sanz I, Pajares JM: Helicobacter pylori and perforated peptic ulcer prevalence of infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis, 2004; 36: 116-20
10. 13C-urea breath test in diagnosis of Helicobacter pylori infection in patients with upper gastrointestinal bleeding. J Clin Gastroenterol, 2003, 37: 34-48
11. Wang WH, Wong WM, Dailidiene D: Aspirin inhibits the growth of Helicobacter pylori and enhance its susceptibility to antimicrobial agents. Gut, 2003; 52: 490-95
12. Stack WAQ, Atherton JC, Hawkey GM et al: Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther, 2002; 16: 497-506
13. Chan FKL, Graham DY: Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment. Aliment Pharmacol Ther, 2004; 19: 1051
14. Graham DY, Klein PD, Opekun AR: In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol, 1989; 84: 233-38
15. Papatheodoridis GV, Papadelli D, Cholongitas E et al. Effect of Helicobacter pylori infection on the risk of upper gastrointestinal bleeeding in users of nonsteroidal anti-inflammatory drugs. Am J Med, 2004; 116: 601-5
16. Huang JQ, Sridhar S, Hunt RH: Role of Helicobacter pylori infection and non-steroidal anri-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet, 2002; 359: 14-22
17. Chan FK, To KF, Wu JC et al: Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting log-term treatment with non-steroidal anti-inflammatory drugs: a randomized trial. Lancet, 2002; 359: 9-13
18. Bazzoli F, Porro G, Bianchi MG et al: Treatment of Helicobacter pylori infection. Indications and regimens: an update. Dig Liver Dis, 2002; 34: 70-83
19. Wong VWS, Wong RWL, Leong FKL: Upper gastrointestinal complications related to non-steroidal anti-inflammatory drugs - what have we achieved so far? Dig Dis Sci, 2004; 36: 1-3